TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early January 5, 1979
TCL Archive In Brief: Takeo Kakanaga Dies; President’s Cancer Panel to Meet Nov. 7; Young To Give Schwartz Lecture October 7, 1988
TCL Archive In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director July 29, 1988
